Skip to main content
Terug
NHI logo

National Health Investors, Inc.

Datakwaliteit: 100%
NHI
NYSE Real Estate REIT - Healthcare Facilities
€ 82,32
▲ € 0,45 (0,55%)
Marktkapitalisatie: 3,99B
Dagbereik
€ 82,14 € 83,81
52-Weeksbereik
€ 66,41 € 91,38
Volume
187.728
50D / 200D Gem.
€ 83,93 / € 77,42
Vorige Slotkoers
€ 81,87

Koershistorie

Financiële Trends

Sectorvergelijking

vs Real Estate sector mediaan (361 peers)

Metriek Aandeel Sector Mediaan
P/E 28,1 11,1
P/B 2,6 0,8
ROE % 9,9 6,1
Net Margin % 37,6 19,9
Rev Growth 5Y % 6,1 7,0
D/E 0,8 0,9

Koersdoel Analisten

Hold
€ 85,20 +3.5%
Low: € 83,00 High: € 88,00
Forward K/W
24,8
Forward WPA
€ 3,32
WPA Groei (sch.)
+0,0%
Omzet Sch.
280 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 0,00
€ 0,00 – € 0,00
310 M 0
FY2029 € 0,00
€ 0,00 – € 0,00
300 M 0
FY2028 € 3,38
€ 3,19 – € 3,58
300 M 1

Belangrijkste Punten

Revenue grew 6,10% annually over 5 years — modest growth
Net margin of 37,56% shows strong profitability
Generating 220,26M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,83%
Cash machine — converts 154,92% of earnings into free cash flow
Capital efficient — spends only 5,27% of revenue on capex

Groei

Revenue Growth (5Y)
6,10%
Revenue (1Y)12,93%
Earnings (1Y)3,04%
FCF Growth (3Y)10,40%

Kwaliteit

Return on Equity
9,85%
ROIC5,44%
Net Margin37,56%
Op. Margin51,47%

Veiligheid

Debt / Equity
0,76
Current Ratio2,48
Interest Coverage3,40

Waardering

P/E Ratio
28,06
P/B Ratio2,62
EV/EBITDA26,35
Dividend Yield0,05%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 12,93% Revenue Growth (3Y) 8,79%
Earnings Growth (1Y) 3,04% Earnings Growth (3Y) 2,38%
Revenue Growth (5Y) 6,10% Earnings Growth (5Y) 6,19%
Profitability
Revenue (TTM) 378,53M Net Income (TTM) 142,18M
ROE 9,85% ROA 5,08%
Gross Margin 36,70% Operating Margin 51,47%
Net Margin 37,56% Free Cash Flow (TTM) 220,26M
ROIC 5,44% FCF Growth (3Y) 10,40%
Safety
Debt / Equity 0,76 Current Ratio 2,48
Interest Coverage 3,40 Dividend Yield 0,05%
Valuation
P/E Ratio 28,06 P/B Ratio 2,62
P/S Ratio 10,54 PEG Ratio -7,19
EV/EBITDA 26,35 Dividend Yield 0,05%
Market Cap 3,99B Enterprise Value 5,13B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 378,53M 335,18M 319,84M 278,19M 298,72M
Net Income 142,18M 137,99M 135,65M 66,40M 111,80M
EPS (Diluted) 3,02 3,13 3,13 0,51 1,36
Gross Profit 138,93M 324,02M 308,32M 268,41M 287,08M
Operating Income 194,83M 183,86M 178,79M 132,77M 185,25M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,80B 2,61B 2,49B 2,51B 2,84B
Total Liabilities 1,26B 1,23B 1,21B 1,22B 1,32B
Shareholders' Equity 1,52B 1,37B 1,25B 1,27B 1,51B
Total Debt 1,16B 1,15B 1,14B 1,15B 1,25B
Cash & Equivalents 19,62M 24,29M 22,35M 19,29M 37,41M
Current Assets 310,22M 396,91M 375,19M 383,01M 514,79M
Current Liabilities 125,00M 414,35M 324,38M 112,01M 70,17M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#539 of 1024
44

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026